Sarkar S, et al. Brain tumors: development, drug resistance, and sensitization—an epigenetic approach. Epigenetics. 2023;18(1):2237761.
Article PubMed PubMed Central Google Scholar
Azzarelli R, Simons BD, Philpott A. The developmental origin of brain tumours: a cellular and molecular framework. Development. 2018;145(10): dev162693.
Article PubMed PubMed Central Google Scholar
Kaza N, Kohli L, Roth KA. Autophagy in brain tumors: a new target for therapeutic intervention. Brain Pathol. 2012;22(1):89–98.
Article PubMed CAS Google Scholar
Xu J, et al. National vital statistics reports. Natl Vital Stat Rep. 2010;58(19):1–136.
Dolecek TA, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol. 2012;14(suppl_5):v1–49.
Article PubMed PubMed Central Google Scholar
Van Meir EG, et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60(3):166–93.
Article PubMed PubMed Central Google Scholar
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.
Article PubMed CAS Google Scholar
Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002;108(2):153–64.
Article PubMed CAS Google Scholar
Reed JC. Apoptosis-based therapies. Nat Rev Drug Discov. 2002;1(2):111–21.
Article PubMed CAS Google Scholar
Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol. 2010;12(9):814–22.
Article PubMed PubMed Central CAS Google Scholar
Schwarze PE, Seglen PO. Reduced autophagic activity, improved protein balance and enhanced in vitro survival of hepatocytes isolated from carcinogen-treated rats. Exp Cell Res. 1985;157(1):15–28.
Article PubMed CAS Google Scholar
De Duve C, Wattiaux R. Functions of lysosomes. Annu Rev Physiol. 1966;28:435–92.
Liang XH, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402(6762):672–6.
Article PubMed CAS Google Scholar
Qu X, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003;112(12):1809–20.
Article PubMed PubMed Central CAS Google Scholar
Yue Z, et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA. 2003;100(25):15077–82.
Article PubMed PubMed Central CAS Google Scholar
Huang X, et al. Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J Clin Neurosci. 2010;17(12):1515–9.
Article PubMed CAS Google Scholar
Pirtoli L, et al. The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy. 2009;5(7):930–6.
Lin J, et al. Tenacissoside H induces autophagy and radiosensitivity of hepatocellular carcinoma cells by PI3K/Akt/mTOR signaling pathway. Dose Response. 2021;19(2):15593258211011024.
Article PubMed PubMed Central CAS Google Scholar
Saleh T, et al. Effect of autophagy inhibitors on radiosensitivity in dna repair-proficient and -deficient glioma cells. Medicina (Kaunas). 2022;58(7):889.
Yang Y, et al. Autophagy and its function in radiosensitivity. Tumour Biol. 2015;36(6):4079–87.
Article PubMed CAS Google Scholar
Li Z, et al. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization. J Exp Clin Cancer Res. 2022;41(1):74.
Article PubMed PubMed Central CAS Google Scholar
Wen H, et al. Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer. Faseb J. 2023;37(9): e23145.
Article PubMed CAS Google Scholar
Huang H, et al. MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer. Cell Death Dis. 2021;13(1):13.
Article PubMed PubMed Central Google Scholar
Wu N, et al. Autophagy in aging-related diseases and cancer: Principles, regulatory mechanisms and therapeutic potential. Ageing Res Rev. 2024;100: 102428.
Article PubMed CAS Google Scholar
Niu X, et al. Complex roles of autophagy in cancer development, immune evasion, and drug resistance. Drug Resist Updates. 2024;78:101170.
Abou-Antoun TJ, et al. Brain cancer stem cells in adults and children: cell biology and therapeutic implications. Neurotherapeutics. 2017;14(2):372–84.
Article PubMed PubMed Central Google Scholar
Čančer M, et al. Humanized stem cell models of pediatric medulloblastoma reveal an Oct4/mTOR axis that promotes malignancy. Cell Stem Cell. 2019;25(6):855-870.e11.
Article PubMed PubMed Central Google Scholar
Willbanks A, et al. The evolution of epigenetics: from prokaryotes to humans and its biological consequences. Genet Epigenet. 2016;8:25–36.
Article PubMed PubMed Central Google Scholar
Romani M, Pistillo MP, Banelli B. Epigenetic targeting of glioblastoma. Front Oncol. 2018;8:448.
Article PubMed PubMed Central Google Scholar
Orozco JIJ, et al. Epigenetic profiling for the molecular classification of metastatic brain tumors. Nat Commun. 2018;9(1):4627.
Article PubMed PubMed Central Google Scholar
Sarkar S, et al. Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. Anticancer Res. 2011;31(9):2723–32.
Campos-Sanchez E, et al. Epigenetic deregulation in human primary immunodeficiencies. Trends Immunol. 2019;40(1):49–65.
Article PubMed CAS Google Scholar
Chen KY, et al. Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling. Commun Biol. 2020;3(1):363.
留言 (0)